The global critical care diagnostics market size was USD 1.1 Bn in 2022 and is likely to reach USD 1.8 Bn by 2031, expanding at a CAGR of 5.6% during 2023–2031. The market growth is attributed to the increasing technological advancement and rising prevalence of infectious diseases and chronic disorders.
Critical care refers to the fulfillment of the requirement of patients who need immediate medical attention due to life-threatening health conditions. In such conditions, patients are usually facing the rapid deterioration of vital organs or are at risk of serious consequences.
Critical care diagnostics tests are extensively performed for intensive care and diagnosis of life-threatening diseases of patients. These tests are widely adopted due to certain advantages such as easy-to-use, rapid, and cost-effective with accurate results. Across the globe, critical care diagnostics are used in the operating room, emergency room, and intensive care units (ICUs).
Rising cases of serious illness, which require admission to the emergency room or urgent medical services present major driving factors for market expansion. As per global health data, around 20% of those who are admitted to hospitals are rushed to emergency rooms.
The rapid growth of various types of technological advancement is another major factor boosting the market. For instance, Abbott combines the i-Stat blood gas analyzer, and self-contained cartridges, with electrochemical detection and microfluidic components to give accurate and sensitive results.
The market report finds that the COVID-19 pandemic has negatively impacted the growth of the market. The implementation of lockdowns and transport bans has affected the production of medical equipment.
Critical Care Diagnostics Market Dynamics
The global critical care diagnostics market report has up-to-date insights that help in formulating a strategic roadmap about the estimated market scenario and performance during 2023 to 2031.
Drivers
Increasing awareness for early diagnosis and treatment among people and rapid development of accurate and cost-effective diagnostic tests are expected to boost the market growth. Wide adoption of data management and connectivity through inter-operability to electronic health records (EHR) is anticipated to push the market expansion. However, the increasing adoption of remote communications and the availability of advanced telehealth services are projected to drive the market growth in the coming years.
Restraints
The lack of skilled professionals for critical care diagnostics and the high cost of tests act as major challenges that can hamper the market expansion during the forecast period.
Opportunities
Ongoing extensive R&D activities to help develop several innovative diagnostic kits are anticipated to create lucrative opportunities for the market players.
Scope of Critical Care Diagnostics Market Report
The global critical care diagnostics market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Critical Care Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2020–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Test Type (Routine & Special Chemistry, Flow Cytometry, Immunoproteins, Microbial & Infectious Diseases, and Others), and Application (Operation Rooms, Emergency Rooms, and Intensive Care Units)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex
|
Critical Care Diagnostics Market Segment Insights
Based on test type, the critical care diagnostics market is segmented into routine & special chemistry, flow cytometry, immunoproteins, microbial & infectious diseases, and others. The immunoproteins segment is expected to represent a key share of the market during the forecast period owing to increasing rapid and accurate diagnosis and also a reduction in the recovery time of patients.
Growing awareness about better healthcare among patients and increasing knowledge of physicians for target therapy are factors responsible for segment growth. Additionally, immunoprotein diagnostic tests are widely used for several applications to detect numerous health conditions that are related to a weakening immune system.
On the basis of application, the market is divided into operation rooms, emergency rooms, and intensive care units (ICUs). The emergency rooms segment is expected to expand at a rapid pace during the forecast period owing to the rising incidence of patients admitted for emergency services. Increasing use of advanced diagnostic tools in hospitals and continuous upgrades of emergency rooms to meet the needs of patients having immediate medical attention are likely to propel the segment growth.
In terms of region, the global critical care diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the global market and is estimated to hold a large market share in the coming years. Key factors that fuel the regional market growth are the presence of major global players, the rising number of geriatric populations, and the early adoption of advanced technology of critical care diagnostic devices.
Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to improved healthcare infrastructure and a growing number of specialized hospitals for intensive care, especially in major economies such as India and China. Additionally, rising improvement of the primary healthcare systems and extended insurance coverage of patients are the new health reforms that boost the regional market growth.
Segments
The global critical care diagnostics market has been segmented on the basis of
Test Type
- Routine & Special Chemistry
- Flow Cytometry
- Immunoproteins
- Microbial & Infectious Diseases
- Others
Application
- Operation Rooms
- Emergency Rooms
- Intensive Care Uniits
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- Beckman Coulter, Inc.
- BD.
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Siemens Healthcare GmbH
- Bio-Rad Laboratories, Inc.
- Chembio Diagnostics, Inc.
- Nanōmix, Inc.
- Sysmex
Competitive Landscape
Key players competing in the global critical care diagnostics market are Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide.
- In August 2020, Philips introduced a Rapid Equipment Deployment Kit for ICU ramp-ups. This kit provides hospitals with a way to quickly and easily expand their critical care capacity.
Request For Customization
Enquiry Before Buying
Speak With Analyst
